IMPACT OF RITUXIMAB ON CHEMOTHERAPY IN THE TREATMENT OF POSTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) AFTER PEDIATRIC LIVER TRANSPLANTATION | Publicación